Fetroja for Intravenous Drip Infusion Regular Drug Use-results Survey

Fetroja for Intravenous Drip Infusion Regular Drug Use-results Survey - Fetroja for Intravenous Drip Infusion Regular Drug Use-results Survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053151

Enrollment

200

Registered

2023-12-19

Start date

2023-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: NA

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Incidence proportions of adverse drug reactions including Safety specification items of Fetroja for Intravenous Drip Infusion	—

Secondary

Measure	Time frame
Clinical effectiveness and bacteriological examinations by bacterial species and infectious disease	—

Countries

Japan

Contacts

Public ContactHaruna Hayashi

SHIONOGI & Co., Ltd. Pharmacovigilance Department

haruna.hayashi@shionogi.co.jp+81-6-6209-6923

Outcome results